Clinical Trial Update: A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC [Phase 2]

View source ↗

Summary

Updates on a Phase 2 study of PM8002 (anti-PD-L1/VEGF) in combination with chemotherapy for extensive-stage small cell lung cancer, with the trial currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• PM8002

Snippet

Sponsor: Biotheus Inc. | Conditions: SCLC | Phase 2 | Status: ACTIVE_NOT_RECRUITING